MRSA Nasal PCR Did Not Reduce Vancomycin Use in ICU Pneumonia Trial
In ICU patients with suspected CAP, MRSA nasal PCR had excellent negative predictive value but did not shorten vancomycin exposure or improve 30-day mortality.
This section contains the website’s posts.